Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases.
Tea Lund LaursenLars BossenRasmus PihlAnne TroldborgThomas Damgaard SandahlAnnette Gudmann HansenTrine FolserassMette VesterhusHenning GrønbækSteffen ThielPublished in: Journal of clinical and translational hepatology (2022)
The plasma concentration of ITIH4 was highly elevated in patients with PBC and PSC, suggesting that ITIH4 should be further investigated as a biomarker in cholestatic liver disease.